ISPOR Good Practices Reports are highly cited, expert consensus guidance recommendations that set international standards for HEOR and its use in healthcare decision making. Other ISPOR Reports provide guidance on important areas such as HTA, health policy, AI and real world evidence. In addition, there are terms and definitions reports and systematic literature reviews on a number of topics . All ISPOR Reports are made freely available as part of the Society’s mission.
ISPOR Report Types
Most Recent
Clinical Outcomes
-
Recommendations on the Selection, Development, and Modification of Performance Outcome (PerfO) Assessments
-
Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes?
-
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness
Economic Evaluation
Epidemiology & Public Health
-
Primer on Health Equity Research in Health Economics and Outcomes Research
-
Comparisons of Food and Drug Administration and European Medicines Agency Risk Management Implementation for Recent Pharmaceutical Approvals
-
Quantitative Risk–Benefit Methodologies for Assessing Drug Safety and Efficacy - Report of ISPOR Risk–Benefit Management Working Group
Health Policy & Regulatory
Health Technology Assessment
Methodological & Statistical Research
-
Generative Artificial Intelligence for Health Technology Assessment: Opportunities, Challenges, and Policy Considerations
-
Recommendations on the Selection, Development, and Modification of Performance Outcome (PerfO) Assessments
-
Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures
Patient Centered Research
-
Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions
-
Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures
-
Quantitative Benefit-Risk Assessment in Medical Product Decision Making
Real World Data & Information Systems
-
Generative Artificial Intelligence for Health Technology Assessment: Opportunities, Challenges, and Policy Considerations
-
Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist
-
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects
Specialized Treatment Areas
-
Mapping Health Technology Assessment Agency Approaches for Biosimilar Value Assessment
-
Are We Ready For A New Approach To Comparing Coverage And Reimbursement Policies For Medical Nutrition In Key Markets
-
Being Precise About Precision Medicine: Report of the ISPOR Personalized Precision Medicine Special Interest Group
Specific Diseases & Conditions
Study Approaches
-
Generative Artificial Intelligence for Health Technology Assessment: Opportunities, Challenges, and Policy Considerations
-
Evolving Use of Health Technology Assessment in Medical Device Procurement—Global Systematic Review
-
Designing and Implementing Deliberative Processes for Health Technology Assessment: Joint HTAi/ISPOR Task Force Report